Clinical Trials Browser

Phase 1/2 × MEK inhibitor I × Clear all

NCT01029418 2015-04-16

AZD6244 and Sorafenib in Advanced Hepatocellular Carcinoma

Phase 1/2 Terminated

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms